We are a Tucson, Arizona based non-profit organization of accredited investors who seek opportunities to invest in Southwest regional startup or early stage companies.
Present your Company
The DESERT ANGELS ™ welcomes applications from startup or early stage companies. We evaluate applications on an ongoing basis and meet monthly from September through June.
Present your company
Become a member
As a vibrant, growing organization, the DESERT ANGELS ™ welcomes new members. If you are an accredited investor with a tenacious appetite for helping early-stage companies succeed, we’d love to get to know you better at an upcoming dinner meeting.
It is safe to say that there would have been no Calimmune without the early support of the Desert Angels.
Many members of the DA share our passion and see the potential for gene therapy to transform healthcare and liberate patients from chronic and incurable diseases. Their investments have helped us grow this company to what it is today. We truly hope Calimmune’s work will be life-changing for the people we plan to serve and the investors that supported us.
The Tucson biotech startup co-founded by UA alumnus Louis Breton in 2006, was acquired in September 2017 by Australia-based CSL Ltd. for $91 million up front and a potential $325 million in performance payments if Calimmune hit milestones including clinical trials for its stem-cell gene therapy to strengthen patients’ own immune systems. https://tucson.com/calimmune-inc/article_d035a0da-bd35-11e9-ae02-f364caa7810c.html
San Francisco-based AngelList Talent has acquired Prospectify, a Tempe tech startup, to bolster its efforts to match startups with talent. Prospectify, which helps sales teams identify and connect with qualified leads, will have its tech and team integrated into AngelList to do the same type of work, but reimagined for job seekers. Prospectify founder and CEO Noah […]